BNP Paribas Fortis SA is a prominent commercial banking institution headquartered in Brussels, Belgium, offering a comprehensive range of financial services both domestically and internationally. The bank serves private individuals, small and medium-sized enterprises, corporations, and public institutions through a network of 590 branches, 270 Fintro branded branches, and 2,734 ATMs. Its services include personal loans, credit and debit cards, investment and insurance products, as well as transaction and investment banking. Additionally, BNP Paribas Fortis specializes in asset management, wealth management services, and real estate services, which encompass property management and investment consulting. Established in 2009, BNP Paribas Fortis operates under the governance of a Board of Directors and is a subsidiary of BNP Paribas. The bank is committed to social responsibility and innovation, reflecting its dedication to meeting customer needs while contributing positively to society.
Hexa is a technology company focused on creating an entrepreneurial ecosystem that supports the development of startup studios. Established in 2011, it initially launched eFounders, a startup studio renowned for its contributions to the B2B SaaS sector, which has successfully launched over 30 companies, including three unicorns. In addition to eFounders, Hexa encompasses Logic Founders, which specializes in fintech, and 3founders, focused on web3. The company aims to democratize entrepreneurship by promoting collaborative company building and expanding its network of startup studios. To date, Hexa's initiatives have resulted in the creation of more than 2,800 jobs and a combined valuation exceeding $5 billion across its portfolio of companies.
Eastern Steel Sdn Bhd
Debt Financing in 2024
Eastern Steel Sdn Bhd is a steel manufacturing company based in Kemaman, Terengganu, Malaysia. Incorporated in 2001, it specializes in operating steel mills and has established a significant presence in the regional steel industry. The company is a subsidiary of Shanxi JianLong Industry Company Limited, which enhances its operational capabilities and market reach. Eastern Steel Sdn Bhd is known for its commitment to producing high-quality steel products to meet the demands of various sectors in the construction and industrial markets.
Stûv
Private Equity Round in 2024
Stûv is a designer and manufacturer of wood-burning appliances, specializing in wood stoves for household and residential use. The company offers a range of products, including wood fireplaces, pellet stoves, and fireplace inserts, aimed at providing efficient and aesthetically pleasing heating solutions. With a focus on quality and design, Stûv combines functionality with modern aesthetics to meet the needs of consumers seeking reliable and stylish heating options for their homes.
Aphea.Bio
Series C in 2023
Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.
Global Infrastructure Partners
Debt Financing in 2022
Global Infrastructure Partners (GIP) is an independent investment firm specializing in infrastructure assets across key sectors such as energy, transportation, and water and waste management. Founded in 2006 and headquartered in New York, GIP focuses on creating value through a disciplined investment approach that emphasizes deep due diligence, strong stakeholder relationships, and proprietary deal sourcing. The firm integrates environmental, social, and governance (ESG) factors into its investment strategy to enhance long-term value for its investors. GIP manages over $51 billion in assets and its portfolio companies generate combined annual revenues exceeding $46 billion, employing more than 52,000 individuals. Additionally, GIP operates a credit arm, GIP Credit, which provides tailored financing solutions for various infrastructure projects, further diversifying its investment capabilities.
MobieTrain
Series B in 2022
MobieTrain is a leading mobile microlearning platform designed to enhance the training and development of frontline teams across various organizations. The platform allows companies to create customized, branded learning tracks utilizing their own training content. By delivering knowledge in short, engaging segments, MobieTrain improves knowledge retention and productivity while significantly reducing content creation and administrative time. It supports employees in acquiring new skills relevant to both their professional and personal lives. The platform incorporates gamification elements to make learning enjoyable and accessible on any mobile device. MobieTrain's innovative approach aids organizations in streamlining onboarding, boosting employee engagement, and enhancing customer experience, ultimately leading to improved performance and satisfaction.
Aircastle
Debt Financing in 2022
Aircastle Limited is a company based in Stamford, Connecticut, that specializes in the leasing, financing, selling, and management of commercial flight equipment for airlines globally. Founded in 2004, Aircastle has built a diverse portfolio of modern and operationally efficient aircraft, which includes 287 jets leased to 85 customers across 49 countries as of December 31, 2019. The company focuses on providing high-utility commercial jet aircraft, ensuring a wide operator base and adapting to the evolving needs of the airline industry. As of March 2020, Aircastle operates as a subsidiary of Marubeni Corporation.
Aquila Capital
Debt Financing in 2022
Aquila Capital is a private investment firm based in Hamburg, Germany, founded in 2001. It specializes in providing institutional investors, pension funds, foundations, and individuals with alternative investment solutions across real assets, financial markets, and private equity. The firm employs a multi-disciplinary investment approach, leveraging a team of dedicated specialists to manage a diverse range of investments, including hedge funds, private equity fund of funds, real estate, and infrastructure projects. Aquila Capital emphasizes strong operational frameworks and corporate governance to enhance its investment management capabilities. The firm operates additional offices in Frankfurt, Munich, and Vienna, and aims to identify and manage attractive investment opportunities for its clients through a solution-oriented approach that encompasses strategy development, implementation, and asset management.
Castore
Venture Round in 2022
Castore is a premium sportswear brand exclusively designed for men, focusing on delivering high-performance apparel tailored for discerning athletes. The company emphasizes technical innovation and meticulous attention to detail in its products, ensuring that each garment meets the demands of serious competitors. By utilizing Italian fabrics and advanced manufacturing techniques, Castore aims to enhance athletic performance under various conditions. The brand is committed to providing quality sportswear that caters to individuals who seek excellence and cannot compromise on performance.
AstriVax
Seed Round in 2022
AstriVax is a biotechnology company focused on developing innovative vaccines that address significant challenges in the field of vaccinology. The company aims to achieve initial clinical validation of its platform technology, which is designed to create a diverse pipeline of vaccines. AstriVax's vaccine candidates are engineered to minimize cold chain requirements, making them more accessible and easier to distribute. Additionally, these vaccines are intended to provide broad and long-lasting protection against a variety of viruses and pathogens, thereby enhancing treatment options within the healthcare sector.
Nobi
Venture Round in 2022
Nobi is a smart lamp that ensures help can be provided in a flash in the event of a fall. It recognizes a fall, and it will notify a family member, contacts, or a specialized emergency call center. The lamp will then connect to that person to reassure them that help is on the way. If necessary, it can even unlock the smart lock on the front door.
Itsme
Venture Round in 2021
Itsme is a mobile application that provides secure digital authentication services, allowing users to verify their identity and safely engage in online transactions. The platform facilitates a range of functions, including logging in to various digital services, confirming online payments, accessing government applications, and signing official documents electronically. By assigning a unique identification to transactions, Itsme ensures user privacy while navigating online environments. The app is designed to deliver a reliable and user-friendly experience for individuals seeking to manage their digital identities securely.
Abbove (PaxFamilia)
Seed Round in 2021
Abbove develops a collaborative wealth planning platform for financial advisors that want to serve their clients with a structured and holistic approach to their wealth. To that end, the solution supports advisors' wealth management activities on three levels: to completely understand their clients' (wealth) situation by providing detailed inventories to store and organise wealth data, to serve their clients with the right advice at the right time with the help of planning and simulation tools (such as a financial planning simulator, inheritance tax calculator and reporting tool) connected to the clients' latest wealth data and to offer their clients continuous support and a unique experience through an intuitive interface that's accessible 24/7 to both advisors, their clients and other trusted third parties.
XenomatiX
Venture Round in 2021
Xenomatix specializes in solid-state light detection and ranging solutions that cater to advanced driver assistance systems (ADAS) and autonomous driving technologies. The company develops automotive vision systems utilizing laser-based technology and complementary metal oxide semiconductor detectors, enabling real-time 3D digitization of vehicle surroundings. Their products are also applicable in various sectors, including road construction, surveying, industrial, automotive, mining, agriculture, off-road activities, and railway operations. By providing innovative solutions, Xenomatix helps enhance safety and efficiency in both automotive and industrial markets.
Dockflow
Pre Seed Round in 2021
Dockflow is a logistics service provider that utilizes a blockchain-based platform to enhance the efficiency and effectiveness of logistics teams. The company specializes in maritime container shipment visibility and tracking, demurrage management, and sensitive cargo monitoring. By automating manual processes and offering collaboration features, Dockflow enables businesses to streamline their operations, allowing logistics teams to concentrate on delivering superior customer service and engaging in more meaningful tasks. The platform addresses the increasing workload faced by logistics professionals, transforming traditional practices and improving overall productivity in the logistics sector.
reMYND
Series B in 2021
reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for neurodegenerative and metabolic disorders, including Alzheimer’s, Parkinson’s, and diabetes. The company is known for its investigational compounds, such as ReS19-T, aimed at treating Alzheimer’s, and ReS39, which targets diabetes. Additionally, reMYND is advancing ReS3-T, a program that addresses both Alzheimer’s and epilepsy by regulating neuronal activity. The company utilizes a phenotypic screening platform to discover small molecule treatments that counteract the toxicity of misfolded proteins associated with these diseases. As a contract research organization (CRO), reMYND also assists clients, including major pharmaceutical companies in the United States, Europe, and Japan, by providing in-vivo assessments of experimental treatments using proprietary mouse models. Founded in 2002, reMYND has established a reputation for delivering pivotal proof-of-concept data that supports drug development in protein misfolding disorders.
MobieTrain
Series A in 2020
MobieTrain is a leading mobile microlearning platform designed to enhance the training and development of frontline teams across various organizations. The platform allows companies to create customized, branded learning tracks utilizing their own training content. By delivering knowledge in short, engaging segments, MobieTrain improves knowledge retention and productivity while significantly reducing content creation and administrative time. It supports employees in acquiring new skills relevant to both their professional and personal lives. The platform incorporates gamification elements to make learning enjoyable and accessible on any mobile device. MobieTrain's innovative approach aids organizations in streamlining onboarding, boosting employee engagement, and enhancing customer experience, ultimately leading to improved performance and satisfaction.
Dockflow
Seed Round in 2020
Dockflow is a logistics service provider that utilizes a blockchain-based platform to enhance the efficiency and effectiveness of logistics teams. The company specializes in maritime container shipment visibility and tracking, demurrage management, and sensitive cargo monitoring. By automating manual processes and offering collaboration features, Dockflow enables businesses to streamline their operations, allowing logistics teams to concentrate on delivering superior customer service and engaging in more meaningful tasks. The platform addresses the increasing workload faced by logistics professionals, transforming traditional practices and improving overall productivity in the logistics sector.
SIRO Ireland
Debt Financing in 2019
SIRO Network is constructed utilizing the overhead and subsurface ESB infrastructure, guaranteeing an efficient, stable, and lengthy network. By deploying optical fiber that enters a home, building, or business directly, is an access network technology that provides the fastest Internet connection imaginable. All constraints that hinder the efficiency of other types of networks are eliminated.
reMYND
Venture Round in 2018
reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for neurodegenerative and metabolic disorders, including Alzheimer’s, Parkinson’s, and diabetes. The company is known for its investigational compounds, such as ReS19-T, aimed at treating Alzheimer’s, and ReS39, which targets diabetes. Additionally, reMYND is advancing ReS3-T, a program that addresses both Alzheimer’s and epilepsy by regulating neuronal activity. The company utilizes a phenotypic screening platform to discover small molecule treatments that counteract the toxicity of misfolded proteins associated with these diseases. As a contract research organization (CRO), reMYND also assists clients, including major pharmaceutical companies in the United States, Europe, and Japan, by providing in-vivo assessments of experimental treatments using proprietary mouse models. Founded in 2002, reMYND has established a reputation for delivering pivotal proof-of-concept data that supports drug development in protein misfolding disorders.
Quality Assistance
Private Equity Round in 2017
Quality Assistance S.A. is a prominent contract research organization based in Thuin, Belgium, specializing in analytical services for the pharmaceutical industry. Established in 1982, the company supports the development and marketing of human medicinal products, including new chemical entities, monoclonal antibodies, and gene therapies. Quality Assistance provides a comprehensive suite of services, including bioanalysis, biochemistry, microbiology, and protein characterization. It also conducts non-clinical and clinical studies, as well as batch release testing, ensuring compliance with EMA and FDA regulations. With a team of 150 highly qualified professionals and all laboratories located on one site, Quality Assistance leverages over 30 years of expertise in analytical sciences to deliver customized solutions and innovative methodologies to pharmaceutical groups and biotechnology companies across Europe, the United States, and beyond.
Ogeda
Series B in 2015
Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that specializes in the invention and development of small molecule drugs targeting G-Protein Coupled Receptors (GPCRs). Founded in 1994 and formerly known as Euroscreen, the company focuses on developing innovative therapies for women's health disorders, with its lead product, fezolinetant, currently in Phase II clinical development. In addition to fezolinetant, Ogeda is advancing other small molecules aimed at treating various endocrine, central nervous system, and inflammatory conditions. The company maintains facilities in Brussels and Paris, and operates as a subsidiary of Astellas Pharma Inc. Through its research, Ogeda seeks to provide effective treatment options for hormone-dependent pathologies and other related health issues.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.